0001209191-19-056643.txt : 20191114
0001209191-19-056643.hdr.sgml : 20191114
20191114214639
ACCESSION NUMBER: 0001209191-19-056643
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191108
FILED AS OF DATE: 20191114
DATE AS OF CHANGE: 20191114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parker Geoffrey M.
CENTRAL INDEX KEY: 0001491874
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 191222310
MAIL ADDRESS:
STREET 1: 15 RIORDAN PLACE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-08
1
0001131324
GENOMIC HEALTH INC
GHDX
0001491874
Parker Geoffrey M.
301 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
1
0
0
0
Common Stock
2019-11-08
4
A
0
955
D
0
D
Director Stock Option (right to buy)
26.07
2019-11-08
4
D
0
20000
D
2026-06-21
Common Stock
20000
0
D
Director Stock Option (right to buy)
31.53
2019-11-08
4
D
0
10000
D
2018-06-16
2027-06-16
Common Stock
10000
0
D
Director Stock Option (right to buy)
51.72
2019-11-08
4
D
0
10000
D
2019-06-07
2028-06-07
Common Stock
10000
0
D
Director Stock Option (right to buy)
52.41
2019-11-08
4
D
0
6583
D
2020-06-14
2029-06-14
Common Stock
6583
0
D
Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences, Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $26,277 and 430 shares of Exact Sciences common stock, having a market value of $79.95 per share, based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $335,468 and 5,494 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019. Pursuant to the terms of the applicable option award agreement, 100% of the unvested options held by the Reporting Person became fully vested following the change in control of the Issuer effected by the Merger.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $145,268 and 2,379 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $62,196 and 1,018 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer restricted stock unit award, whether or not vested, was cancelled in exchange for a cash payment of $39,074 and 640 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019. Pursuant to the applicable option award agreement, 100% of the unvested options held by the Reporting Person became fully vested following the change in control of the Issuer effected by the Merger.
/s/ G. Bradley Cole, Attorney-in-fact
2019-11-14